# Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin

> **NCT01525823** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 26 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BMS-754807 (IGR-IR/IR Inhibitor)
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01525823
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01525823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01525823, "Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01525823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*